跳至主要内容
临床试验/NCT06201585
NCT06201585尚未招募不适用

Single-port Robot-assisted Surgery for Gastric Cancer

Hebei Medical University1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2024年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
10
试验地点
1
主要终点
The rate of intraoperative complications

研究概览

简要总结

This clinical study was a prospective, single-center, single-arm exploratory study. Subjects who meet the inclusion criteria will be enrolled in this study, where surgeons will perform single-port robot-assisted gastrectomy, and explore and evaluate the safety and efficacy of this clinical application.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥18 years old and age ≤80 years old, regardless of gender;
  • patients who met the surgical indications and were confirmed by the investigator to be in need of laparoscopic surgery.
  • patients with American Society of Anesthesiologists (ASA) physical status classification ⅰ-ⅲ.
  • Be able to cooperate with the completion of visits and related examinations specified in the protocol.
  • Subjects voluntarily participated in the clinical trial and agreed or their guardians agreed to sign an informed consent.

排除标准

  • patients with severe heart, lung, brain, liver, or kidney diseases can not tolerate surgery or anesthesia;
  • those who cannot tolerate pneumoperitoneum;
  • patients with serious systemic diseases that are not suitable for surgical treatment according to the judgment of the investigator;
  • patients with a history of severe bleeding disease, hematopoietic dysfunction or coagulation dysfunction, who are not suitable for surgical treatment according to the judgment of the investigator, and long-term use of anticoagulant and antiplatelet drugs (antiplatelet aggregation drugs were discontinued less than 1 week before surgery);
  • patients with active pulmonary tuberculosis;
  • HIV antibody positive; Hepatitis B surface antigen (HbsAg) positive and hepatitis B virus DNA (HBV-DNA) copy number higher than the detection limit or normal range; Hepatitis C virus (HCV) antibody positive; Patients with positive treponema pallidum antibody and high risk of infection judged by the researcher;
  • with epilepsy, psychiatric history or cognitive impairment;
  • pregnant and lactating women;
  • Extensive and severe adhesion in the abdominal cavity caused the inability to perform puncture to establish pneumoperitoneum, and it was difficult to isolate and expose the lesion; A history of major abdominal surgery and abdominal radiotherapy were included, according to the investigator's judgment Situations where there is a risk of extensive adhesion;
  • participants who participated in other interventional clinical trials within 3 months before screening;
  • other circumstances that the investigator deemed inappropriate to participate in the trial.

研究组 & 干预措施

Single-port robot-assisted gastrectomy

Experimental

SHURUI Endoscopic Surgical Robotic System (SR-ENS-600)

干预措施: SHURUI Endoscopic Surgical Robotic System (SR-ENS-600) (Device)

结局指标

主要结局

The rate of intraoperative complications

时间窗: The day of surgery

Intraoperative complications, including organ injury and vascular injury, were evaluated

The rate of postoperative complications

时间窗: Postoperative 30 days

Postoperative complications, including postoperative bleeding, fever, and incisional infection, were evaluated using the Clavien-Dindo grading system to determine whether the occurrence of complications was related to the study instrument or surgery.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Qun Zhao

Hebei Medical University

Hebei Medical University

研究点 (1)

Loading locations...

相似试验

Exploratory Study of Single-port Robot-assisted... | 临床试验